Abstinence Ideology and Somatic Treatment for Addicts - Ethical Considerations

References

• Backmund, M. (2002). Interferon therapy and detoxification treatment. Suchttherapie, 3 (suppl.), S67–S71.
   Google Scholar
• Backmund, M., Meyer, K., von Zielonka, M. and Eichenlaub, D. (2001). Treatment of hepatitis C infection in injection drug users. Hepatology, 34(1),188–193.
   PubMed Web of Science ®Google Scholar
• Berkman, L. and Kawachi, I. (Eds.) (2000). Social Epidemiology. Oxford University Press, Oxford. Blackwell, J. (1988). Sin, sickness or social problem? The concept of drug dependence. In:Blackwell, J. and Erickson, P. (Eds.), Illicit Drugs in Canada. Nelson, Toronto.
   Google Scholar
• Broers, B., Morabia, A. and Hirschel, B. (1994). A cohort study of drug user’s compliance with zidovudine treatment. Archives of Internal Medicine, 154, 1121–1127.
   PubMed Web of Science ®Google Scholar
• Conrad, P. (1981). On the medicalization of deviance and social control. In: Ingleby, D. (Ed.), Critical Psychiatry, pp. 102–119. Penguin, Harmondsworth.
   Google Scholar
• Dalgard, O., Bjoro, K., Hellum, K., Myrvang, B., Skaug, K., Gutigard, B., Bell, H. and the Construct Group. (2002). Treatment of chronic hepatitis C in injection drug users: 5 years’ follow-up. European Addiction Research, 8(1),45–49.
   PubMed Web of Science ®Google Scholar
• Davis, G.L. and Rodrigue, J.R. (2001). Treatment of chronic hepatitis C in active drug users. New England Journal of Medicine, 345(3),215–217.
   PubMed Web of Science ®Google Scholar
• DiMartini, A., Weinrieb, R. and Fireman, M. (2002). Liver transplantation in patients with alcohol and other substance use disorders. Psychiatric Clinics of North America, 25(1),195–209.
   PubMedGoogle Scholar
• Edlin, B.R., Seal, K.H., Lorvick, J., Kral, A.H., Ciccarone, D.H., Moore, L.D. and Lo, B. (2001). Is it justifi- able to withhold treatment for hepatitis C from illicit-drug users? New England Journal of Medicine, 345(3),211–214.
   PubMed Web of Science ®Google Scholar
• Fireman, M. and Rabkin, J.M. (2001). Outcome of liver transplantation in patients with alcohol and other chemical dependence. Psychosomatics, 42(2),172–173.
   Google Scholar
• Fischer, B. and Rehm, J. (2001). Some reflections on the relationship of risk, harm and responsibility in recent tobacco lawsuits, and implications for public health. Canadian Journal of Public Health, 92, 7–8.
   PubMedGoogle Scholar
• Fischer, B., Rehm, J., Baliunas, D., Kim, G., Stephenson, D., Robins, A. and Haydon, E. (2002). OPICAN Toronto Site: Baseline Data Overview, Presented at IHRT All-Projects Conference, Toronto.
   Google Scholar
• Flavin, D.K., Niven, R.G. and Kelsey, J.E. (1988). Alcoholism and orthotopic liver transplantation. JAMA: Journal of the American Medical Association, 259(10),1546–1547.
   PubMedGoogle Scholar
• Glannon, W. (1998). Responsibility, alcoholism, and liver transplantation. Journal of Medicine and Philosophy, 23(1),31–49.
   PubMed Web of Science ®Google Scholar
• Gusfield, J. (1993). The social symbolism of smoking and health. In: Rabin, R. and Sugarman, S. (Eds.), Smoking Policy: Law, Politics and Culture. Oxford University Press, New York.
   Google Scholar
• Gutfreund, K.S. and Bain, V.G. (2000). Chronic viral hepatitis C: management update. Canadian Medical Association Journal, 162(6),827–833.
   Google Scholar
• Harvey, E.L. and Hill, A.J. (2001). Health professionals’ views of overweight people and smokers. International Journal of Obesity, 25, 1253–1261.
   Web of Science ®Google Scholar
• Heathcote, J.E., Yim, C., Thai, Q. and Sherker, A. (2001). Your Personal Health Series (Canadian Medical Association): Hepatitis C. Key Porter Books, Toronto.
   Google Scholar
• Jarvis, M.J., Belcher, M., Vesey, C. and Hutchinson, D.C. (1986). Low cost monoxide monitors in smoking assessment. Thorax, 41, 886–887.
   PubMed Web of Science ®Google Scholar
• Ju¨ rgens, R. (1995). Legal and Ethical Issues Raised by HIV/AIDS: Literature Review and Annotated Bibliography. Canadian AIDS Society and Canadian HIV/AIDS Legal Network, Montre´ al.
   Google Scholar
• Kahneman, D. and Tversky, A. (Eds.) (2000). Choices, Values, and Frames. Cambridge University Press, Cambridge.
   Google Scholar
• Karman, J.F., Sileri, P., Kamuda, D., Cicalese, L., Rastellini, C., Wiley, T.E., Layden, T.J. and Benedelti, E. (2001). Risk factors for failure to meet listing requirements in liver transplant candidates with alcoholic cirrhosis. Transplantation, 71(9),1210–1213.
   PubMedGoogle Scholar
• Kluge, E.H. (1994). Drawing the ethical line between organ transplantation and lifestyle abuse. Canadian Medical Association Journal, 150(5),745–746.
   Google Scholar
• Krajden, M. (2002). Personal communication.
   Google Scholar
• Lamothe, F., Vincelette, J., Bruneau, J., Tepper, M., Gully, P.R., Lachance, N. and Franco, E. (1997). Prevalence, seroconversion rates and risk factors for hepatitis B core, hepatitis C and HIV antibodies among intravenous drug users (IDU) of the Saint-Luc Cohort (abstract 221). 6th Annual Canadian Conference on HIV/AIDS Research, May 1997. Canadian Journal of Infectious Diseases, 8(suppl. A), 28A.
   Google Scholar
• Leshner, A.I. (1997). Addiction is a brain sisease, and it matters. Science, 278, 45–48.
   PubMed Web of Science ®Google Scholar
• Lollis, C.M., Strothers, H.S., Chitwood, D.D. and McGhee, M. (2000). Sex, drugs and HIV: does methadone maintenance reduce drug use and risky sexual behavior? Journal of Behavioral Medicine, 23, 545–557.
   PubMed Web of Science ®Google Scholar
• Middleton, E.T. and Morice, A.H. (2000). Breath carbon monoxide as an indication of smoking habit. Chest, 117, 758–763.
   PubMed Web of Science ®Google Scholar
• Moatti, J.P., Carrieri, M.P., Spire, B., Gastaut, J.A., Cassuto, J.P. and Moreau, J. (2000). Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. AIDS, 14, 151–155.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health (2002). Management of Hepatitis C: Final Statement. National Institutes of Health, Washington.
   Google Scholar
• Neri, S., Bruno, C.M., Abate, G., Ierna, D., Mauceri, B., Cilio, D. et al. (2002). Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2b. Clinical Therapeutics, 24(10),1627–1635.
   PubMed Web of Science ®Google Scholar
• Patrick, D., Buxton, J., Bigham, M. and Mathias, R. (2000). Public health and hepatitis C. Canadian Journal of Public Health, 91(suppl. 1), S18–S21.
   Google Scholar
• Patrick, D., Tyndall, M., Cornelisse, P., Li, K., Sherlock, C.H., Rekart, M.L., Strathdee, S.A., Currie, S.L., Schechter, M. and O’Shaughnessy, M.V.O. (2001). Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Canadian Medical Association Journal, 165(7),889–895.
   PubMed Web of Science ®Google Scholar
• Pereira, S.P., Muiesan, P., Howard, L., Rela, M., Heaton, N. and Williams, R. (1997a). Long-term survival and alcohol relapse after liver transplantation for alcoholic liver disease. Gut, 40(suppl. 1), A18.
   Google Scholar
• Pereira, S.P., Muiesan, P., Howard, L., Rela, M., Heaton, N. and Williams, R. (1997b). Long-term survival and quality of life after liver transplantation for alcoholic liver disease. Gut, 41(suppl. 3), A78.
   Google Scholar
• Poulin, C., Single, E. and Fralick, P. (1999). Canadian Community Epidemiology Network on Drug Use (CCENDU): Second National Report. Canadian Centre on Substance Abuse, Ottawa.
   Google Scholar
• Rehm, J., Room, R., Monteiro, M., Gmel, G., Graham, K., Rehn, N., Sempos, C.T., Frick, U. and Jernigan, D. (in press). Alcohol. In: WHO (Ed.), Comparative Quantification of Health Risks: Global and Regional Burden of Disease Due to Selected Major Risk Factors. WHO, Geneva.
   Google Scholar
• Remis, R.S., Hogg, R.S., Krahn, M.D., Preiksaitis, J.K. and Sherman, M. (1998a). Estimating the Number of Blood Transfusion Recipients Infected by Hepatitis C in Canada, 1960–1985 and 1990–1992. Laboratory Centre for Disease Control, Ottawa.
   Google Scholar
• Remis, R., Leclerc, P., Routledge, R., Taylor, C., Bruneau, J., Beauchemin, J., Millson, P., Palmer, R., Degani, N., Strathdee, S. and Hogg, R. (1998). Consortium to Characterize Injection Drug Users in Canada (Montreal, Toronto and Vancouver), Report produced for Health Canada.
   Google Scholar
• Roizen, R. (1987). The great controlled-drinking controversy. In: Galanter, M. (Ed.), Recent Developments in Alcoholism, Vol. 5, pp. 245–279. Plenum, New York.
   Google Scholar
• Room, R. (1985). Dependence and society. British Journal of Addiction, 80, 133–139.
   PubMedGoogle Scholar
• Salomon, N., Perlman, D.C., Rubenstein, A., Mandelman, D., McKinley, F.W. and Yncovityz, S.R. (1997). Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program. International Journal of Tuberculosis and Lung Disease, 1, 397–404.
   PubMedGoogle Scholar
• Siegler, M. and Oswald, S. (1968). Models of drug addiction. International Journal of Addiction, 3, 3–24.
   Web of Science ®Google Scholar
• Steffen, T., Bladiettler, R., Gutzwiller, F. and Zwahlen, M. (2001). HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription program. European Journal of Public Health, 11, 425–430.
   PubMed Web of Science ®Google Scholar
• Sylvestre, D.L. (2002). Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug and Alcohol Dependence, 67(2),117–123.
   PubMed Web of Science ®Google Scholar
• Tesh, S.N. (1988). Hidden Arguments: Political Ideology and Disease Prevention Policy. Rutgers University Press, New Brunswick, NJ.
   Google Scholar
• The Hepatitis Information Network (2002). Hep C: transmission. The Hepatitis Knowledge Newsletter, 1 (2).Valverde, M. (1998). Diseases of the Will: Alcohol and the Dilemmas of Freedom. Cambridge University Press, Cambridge.
   Google Scholar
• Wendt, C.H., Zirbes, J.M., Elmajri, D.E. and Dunbar, J.S. (2001). Pretransplant issues. In: Hertx, M.I. (Ed.), Manual of Lung Transplant Medical Care, 2nd edition (Chapter 2). Fairview Press, Minneapolis. [http://www.medscape.com/viewarticle/404417]
   Google Scholar
• Zaric, G.S., Barnett, P.G. and Brandeau, M.L. (2000). HIV transmission and cost-effectiveness of methadone maintenance. American Journal of Public Health, 90, 1100–1111.
   PubMed Web of Science ®Google Scholar
• Zou, S., Tepper, M. and Giulivi, A. (2000). Current status of hepatitis C in Canada. Canadian Journal of Public Health, 91(suppl.1), S10–S15.
   Google Scholar